. >> it's martha brumfield. if i could add onto tom's point, my experience and, of course,s disagree please speak up was that the regulators with whom we were interacting in the countries were very enthusiastic about this initiative and anxiously awaiting the report. so the i think there is a lot of receipt activity on the part of many of these regulatory agencies. so it's not just for g-20 to push it, although i think this is incredibly important but there can be other mechanisms maybe softer, one-on-one type of approaches where there would be a lot of receipt activity with the agencies in the developing countries. >> and i think we can be -- one of the things we recommend here is international standards to make it easy for them. one of the things we found, we did, as you mentioned a lot of field visits as part of this committee and we often found strong regulatory systems in the areas that support products for export. that don't necessarily extend to the population at large. and there is a lot we can do both t

. >> martha brumfield, also from the committee. i would like to add, we have to be mindful of the other side of the committee and what congress has to undertake. this is not a u.s. problem. this is a global problem. even simple things like sherry and inspection reports, there may be lost -- laws that prevent sharing. we need to make this a two way dialogue. >> our hope is to bring this to be g-20 agenda and get everyone on the same page. -- the g-20 agenda and get everybody on the same page. >> trade and development on these issues operates internationally. it is not just about public health. it said operate domestically as well. hopefully, that allows the ability to bring together the necessary partners you need to bring to bear on this problem. >> thank you very much. if you would like to ask a question, priest -- please press star 1. >> yes? >> i am with the global health technology coalition. the soy curious about the second set of recommendations -- i am curious about the second set of recommendations. they are not waiting for

. >> it's ma that -- martha brumfield, to build on tom's point, the regulators with whom we were interacting in the countries were very enthusiastic about this initiative and are anxiously awaiting the report. so i think there is a lot of reaccepttivity on the part of many of these regulatory agencies. so it's not just for g20 to push it, although i think that is incredibly important. but i think there can be other mechanisms maybe softer, one-on-one types of approaches where there'd be a lot of retentivity with the -- receptivity in the developing countries. >> and one of the things we recommend here again is international standards to make it easy for them. one of the things we found, we did, as jim mentioned, a lot of field visits as part of this committee, and we often found strong regulatory systems in the areas that support products for export. that don't necessarily extend to the population at large. and there is a lot we can do both the u.s. specifically by doing more to support international standards and the participation of developing country agencies and their development, but al